[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353563-105":59,"doc-detail-353563-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cap1-mediated-m6a-modification-of-rrm2-suppresses-tumor-associated-m2-macrophage-polarization-and-colorectal-cancer-growth","CAP1-Mediated m6A modification of RRM2 suppresses tumor - associated M2 macrophage polarization and colorectal cancer growth","","Colorectal cancer (CRC) progression is shaped by dynamic interactions between tumor cells and tumor-associated macrophages (TAMs), which drive an immunosuppressive microenvironment. This study identifies CAP1 as a regulator of this crosstalk via RNA methylation-dependent control of M2 macrophage polarization. CAP1 is significantly downregulated in CRC tissues and correlates with survival. CAP1 loss enhances tumor growth in immunocompetent mice by increasing ALKBH5-mediated m6A methylation, elevating RRM2 translation and secretion, promoting M2 polarization and CRC proliferation, and supporting RRM2 inhibition as therapy for CAP1-low tumors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cap1-mediated-m6a-modification-of-rrm2-suppresses-tumor-associated-m2-macrophage-polarization-and-colorectal-cancer-growth/353563/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cap1-mediated-m6a-modification-of-rrm2-suppresses-tumor-associated-m2-macrophage-polarization-and-colorectal-cancer-growth/353563.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does CAP1 play in colorectal cancer progression?","Question",{"text":112,"@type":113},"CAP1 regulates tumor-associated macrophage polarization through RNA methylation-dependent mechanisms. CAP1 is downregulated in CRC tissues, and lower CAP1 is linked to worse outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why does CAP1 knockdown enhance tumor growth in vivo?",{"text":117,"@type":113},"Although CAP1 knockdown shows no clear cell-autonomous proliferation effect in vitro, it dramatically enhances tumor growth in immuno-competent mouse models through immune microenvironment changes.",{"name":119,"@type":110,"acceptedAnswer":120},"How is RRM2 connected to CAP1 and TAM M2 polarization?",{"text":121,"@type":113},"CAP1 deficiency triggers ALKBH5-mediated increases in m6A RNA methylation, which enhances translation and secretion of RRM2. Tumor-derived RRM2 then drives M2 polarization of TAMs, creating a pro-tumor niche that supports CRC cell proliferation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353563,1790891111,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Cellular and Molecular Life Sciences (2026) 83:64  \n[https://doi.org/10.1007/s00018-025-06031-x](https://doi.org/10.1007/s00018-025-06031-x) Cellular and Molecular Life Sciences  \nORIGINAL ARTICLE  \nCAP1-Mediated m6A modification of RRM2 suppresses tumor  \nassociated M2 macrophage polarization and colorectal cancer growth  \nTianlin Feng1,2 · Ling Lin1 · Xiaoya Zhou1,4 · Li Li1 · Yao Chen1 · Wenyi Zheng5 · Qinrui Cai1 · Dongling Li1,6 · Jianshan Lin1,4 · Qianyao Wang1,4 · Wei Li3 · Xiaoyuan Zheng2 · Fan Yang1  \nReceived: 14 August 2025 / Revised: 15 November 2025 / Accepted: 10 December 2025 © The Author(s) 2026  \nAbstract  \nColorectal cancer (CRC) progression is critically regulated by dynamic interactions between tumor cells and tumorassociated macrophages (TAMs), which shape the immuno-suppressive tumor microenvironment. In this study, we identify CAP1 as a novel regulator of this crosstalk through its control of RNA methylation-dependent M2 macrophage polarization. Clinical analysis reveals significant CAP1 downregulation in CRC tissues compared to adjacent normal mucosa, with its expression positively correlating with patient survival outcomes. While CAP1 knockdown did not show cellautonomous effects on CRC proliferation in vitro, it dramatically enhanced tumor growth in immuno-competent mouse models. Further mechanistic studies uncover that CAP1 deficiency in tumor cells triggers a ALKBH5-mediated increase inm⁶A RNA methylation, specifically enhancing the translation and secretion of RRM2 . This tumor-derived RRM2 potently drives M2 polarization of TAMs, creating a pro-tumorigenic niche that facilitated the proliferation of CRC cells in turn. Moreover, the RRM2 inhibitor shows considerable efficacy in treating tumors with low expression of CAP1 . Collectively, this study provides new insights into how tumor cells regulate immune responses through post-transcriptional modification and suggests potential therapeutic strategies targeting the CAP1-RRM2 axis in CAP1-deficient CRCs.  \nKeywords Colorectal cancer · CAP1 · RRM2 · M6A · Macrophage polarization  \nTianlin Feng, Ling Lin contributed equally to this work.  \n􀀍 Wei Li[liwei00128@cqu.edu.cn](liwei00128@cqu.edu.cn)  \n􀀍 Xiaoyuan Zheng [XiaoyuanZheng20@126.com](XiaoyuanZheng20@126.com)  \n􀀍 Fan Yang [yangfanbio@cqu.edu.cn](yangfanbio@cqu.edu.cn)  \n1 Central Laboratory of Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University, Chongqing 400014, China  \n2 Pharmacy Department, Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University, Chongqing 400014, China  \n3 Department of Plastic Surgery, Chongqing Emergency Medical Center, Chongqing University Central Hospital, Chongqing 400014, China  \n4 College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China  \n5 College of Pharmacy, Chongqing Medical University, Chongqing 400016, China  \n6 National Science Library (Chengdu), Chinese Academy of Sciences, Chengdu 610041, China  \nIntroduction  \nColorectal cancer (CRC) is one of the most common malignant tumors, with the second highest number of new diagnoses in women and the third highest in men, and causing approximately 90,000 deaths annually worldwide [1–3] . Advancements in medical science have led to significant improvements in the clinical management of colorectal cancer (CRC) . Traditional treatments, including surgical resection, chemotherapy and radiotherapy, combined with emerging therapies such as targeted therapy and immunotherapy have collectively enhanced patient outcomes. Nevertheless, these treatments still face many challenges including high recurrence rates, severe adverse reactions, inadequate drug specificity, and the development of resistance. Consequently, reveal the molecular mechanisms of CRC pathogenesis and identify novel therapeutic targets are essential to further improve clinical efficacy and patient pr","cbCaik9dA4EXxgFe","https://ap.wps.com/l/cbCaik9dA4EXxgFe","pdf",14137661,15,"English","# Abstract\n## Keywords\n# Introduction\n## CAP1 and colorectal cancer context\n## Tumor microenvironment and TAM polarization","[{\"question\":\"What role does CAP1 play in colorectal cancer progression?\",\"answer\":\"CAP1 regulates tumor-associated macrophage polarization through RNA methylation-dependent mechanisms. CAP1 is downregulated in CRC tissues, and lower CAP1 is linked to worse outcomes.\"},{\"question\":\"Why does CAP1 knockdown enhance tumor growth in vivo?\",\"answer\":\"Although CAP1 knockdown shows no clear cell-autonomous proliferation effect in vitro, it dramatically enhances tumor growth in immuno-competent mouse models through immune microenvironment changes.\"},{\"question\":\"How is RRM2 connected to CAP1 and TAM M2 polarization?\",\"answer\":\"CAP1 deficiency triggers ALKBH5-mediated increases in m6A RNA methylation, which enhances translation and secretion of RRM2. Tumor-derived RRM2 then drives M2 polarization of TAMs, creating a pro-tumor niche that supports CRC cell proliferation.\"}]","CAP1-Mediated m6A modification of RRM2 suppresses tumor - associated M2 macrophage polarization and colorectal cancer growth | PDF",1790106050,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b6fa4fae25eb05d933e10cd78ed088d.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83ee26c4b2b9bddde29927aa864af1c3.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e82048b22bd31a4ef48f1167f74db60.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a73191b6213a082bc22cc7789970aa3.webp",980,1301]